publication date: Jul. 2, 2015

BSA Approves Three Concepts at Joint Meeting with NCAB


The NCI Board of Scientific Advisors approved the following concepts at a meeting June 24:

• The Non-Communicable Disease Regional Infrastructure Core Planning Grants program seeks to support activities for the planning and designing of sustainable, regional research infrastructure core, established to build, strengthen, and coordinate research and training of non-communicable diseases in low and middle-income countries or regions.

The long-term goals of NCD RICs include: strengthening commitment of LMIC countries to public health research and implementation, building evidence base for NCD prevention and control in LMICs, building global health career track for investigators focused on NCDs, facilitating individual research projects through the use of Regional Research Cores, and strengthening multidisciplinary research across NCDs.

Challenges facing NCDs in LMICs include: limited in-country financial support for research and training, inadequate research infrastructures, poor healthcare delivery services, which limit the ability to conduct clinical research, lack of surveillance regarding the management of NCDs, and lack of coordination across activities for addressing NCDs at country and regional-levels.

NCI expects to make six, two-year, $200,000 direct cost awards and $1.2 million in direct costs per year, in fiscal 2016 and 2017. The new program will be run through the Center for Global Health.


• The Clinical Proteomic Tumor Analysis Consortium aiming to elucidate the proteogenomic complexity of tumors by identifying proteins that derive from alterations in cancer genomes—including TCGA tumors such as colorectal cancer, ovarian cancer and breast cancer.

Continue reading 41-26 BSA Approves Three Concepts at Joint Meeting with NCAB

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.